BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8599273)

  • 1. Hypothesis: angiogenesis cytokines in high altitude cerebral oedema.
    Severinghaus JW
    Acta Anaesthesiol Scand Suppl; 1995; 107():177-8. PubMed ID: 8599273
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenesis-regulating cytokines: activities and interactions.
    Pepper MS; Mandriota SJ; Vassalli JD; Orci L; Montesano R
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 2)():31-67. PubMed ID: 9053296
    [No Abstract]   [Full Text] [Related]  

  • 3. [Angiogenic factors in endometriosis].
    Fujimoto J; Tamaya T
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():65-9. PubMed ID: 11235180
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor angiogenesis].
    Ono M; Kuwano M
    Seikagaku; 1998 Sep; 70(9):1159-70. PubMed ID: 9796411
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    Relf M; LeJeune S; Scott PA; Fox S; Smith K; Leek R; Moghaddam A; Whitehouse R; Bicknell R; Harris AL
    Cancer Res; 1997 Mar; 57(5):963-9. PubMed ID: 9041202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vascular cell integrins alpha v beta 3 and alpha v beta 5 in angiogenesis.
    Varner JA
    EXS; 1997; 79():361-90. PubMed ID: 9002227
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiogenesis and angiogenesis inhibition: an overview.
    Folkman J
    EXS; 1997; 79():1-8. PubMed ID: 9002217
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of retinal and choroidal neovascularization.
    D'Amore PA
    Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):3974-9. PubMed ID: 7525506
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of angiogenic growth factors in breast cancer progression.
    Kern FG; Lippman ME
    Cancer Metastasis Rev; 1996 Jun; 15(2):213-9. PubMed ID: 8842493
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.
    Samoto K; Ikezaki K; Ono M; Shono T; Kohno K; Kuwano M; Fukui M
    Cancer Res; 1995 Mar; 55(5):1189-93. PubMed ID: 7532545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: a goal for therapeutic angiogenesis?
    Carmeliet P
    Circ Res; 2000 Aug; 87(3):176-8. PubMed ID: 10926865
    [No Abstract]   [Full Text] [Related]  

  • 12. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium.
    Melder RJ; Koenig GC; Witwer BP; Safabakhsh N; Munn LL; Jain RK
    Nat Med; 1996 Sep; 2(9):992-7. PubMed ID: 8782456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis as a biologic and prognostic indicator in human breast carcinoma.
    Engels K; Fox SB; Harris AL
    EXS; 1997; 79():113-56. PubMed ID: 9002231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in ovarian cancer.
    Brown MR; Blanchette JO; Kohn EC
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Dec; 14(6):901-18. PubMed ID: 11141340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.
    Miller JW; Adamis AP; Aiello LP
    Diabetes Metab Rev; 1997 Mar; 13(1):37-50. PubMed ID: 9134347
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.
    Brenchley PE
    Clin Exp Immunol; 2000 Sep; 121(3):426-9. PubMed ID: 10971506
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple angiogenesis stimulators in a single malignancy: implications for anti-angiogenic tumour therapy.
    Pavlakovic H; Havers W; Schweigerer L
    Angiogenesis; 2001; 4(4):259-62. PubMed ID: 12197470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E; Skopińska-Rózewska E; Sommer E; Pastewka K; Chorostowska-Wynimko J; Sokolnicka I; Kazoń M
    Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C; Ortega N; Bayard F; Plouet J
    Diabetes Metab; 1996 Jul; 22(4):268-73. PubMed ID: 8767174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation.
    Gale NW; Thurston G; Davis S; Wiegand SJ; Holash J; Rudge JS; Yancopoulos GD
    Cold Spring Harb Symp Quant Biol; 2002; 67():267-73. PubMed ID: 12858549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.